AI Insight
This study examined a DNA methylation score (MD-MS) derived from blood samples to predict depression course and risk factors in 731 individuals over six years. The MD-MS was elevated in people with lifetime major depressive disorder compared to controls and was associated with lower social activity, higher inflammatory markers (CRP), elevated triglycerides and glucose levels, and lower air pollution exposure. Individuals with chronic depression showed consistently higher MD-MS scores over time, and psychosocial factors like social activity and childhood trauma partially explained the association between MD-MS and depression.
Why it matters
This research suggests that blood-based epigenetic markers could potentially help identify biological signatures of depression and its risk factors. Understanding how psychosocial and biological factors influence depression-related DNA methylation patterns may eventually lead to new preventive or treatment strategies, though the effect sizes observed were modest.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Background: DNA methylation (DNAm) signatures of major depressive disorder (MDD) may be related to psychosocial, environmental, biological, and lifestyle risks. We tested a blood-based DNAm depression score (MD-MS) based on an existing EWAS (N = 24,754) in N = 731 individuals for predicting 8 clinical and 16 MDD risk factors and whether different MDD trajectories mapped to changes in MD-MS over six years. Methods: We calculated the MD-MS based on the top 15 strongest, epigenome-wide significant depression associated sites from the largest EWAS to date in EPICv2-profiled blood samples from N = 366 NESDA participants at baseline and N = 365 at six-year follow-up (FU6). Sixty percent of participants obtained a lifetime MDD diagnosis before or during the study timeframe. Linear mixed effect models were used for all analyses. Results: The MD-MS was elevated in lifetime MDD vs. controls ({beta}=0.137, p=0.012). Lower social activity ({beta}=0.051, p=0.043), CRP ({beta}=0.068, p=0.006), triglycerides ({beta}=0.055, p=0.036) and fasting glucose ({beta}=0.059, p=0.025) showed positive associations with MD-MS, while higher neighborhood air pollution levels showed a negative association ({beta}=-0.054, p=0.031). Adjustment for psychosocial variables (social activity, childhood trauma, partner status) attenuated the MD-MS association with lifetime MDD by 17.5% ({beta}=0.114, p=0.051). Longitudinally, individuals with chronic MDD exhibited consistently higher MD-MS compared to controls ({beta} = 0.295, p = 0.001). Conclusions: The MD-MS captures an epigenetic signature of lifetime exposure to MDD. The significant influences of psychosocial and biological factors on this association, although of limited effect size, warrant further research on potentially actionable mechanisms against aberrant depression-related DNAm patterns.
Source: The relation of a blood DNA methylation score with six-year depression course and risk factors